secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001822479-25-000041
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q2 revenue up 6.4% to $294M; Adj EBITDA +9.8% to $151M; raises FY outlook
--------------------------------------------------------------------------------

- Q2 net revenues $294M (+6.4% YoY); constant currency +6.0%; net income $8M ($0.03 diluted EPS).
- Adjusted EBITDA $151M (+9.8% YoY); Adjusted EPS $0.20 vs $0.19 prior year.
- Company raises full-year 2025 outlook: net revenue growth 4.5%-6.0%, Adj EBITDA growth 6.0%-7.5% constant currency.
- Net income impacted by $34M pending settlement related to ethylene oxide claims against Sterigenics.
- First-half 2025 net revenues $549M (+4.6% YoY); net loss $5M due to settlements totaling $65M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/0001822479-25-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/shc-20250808.htm
  HTML page:      https://secwatch.observer/filing/0001822479-25-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer